Carolyn M. Zelop
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Carolyn M. Zelop has a total of 189 co-authors. Here are the top co-authors by number of shared publications:
Ann E. Podrasky
3 shared publications- Ashish R. Panchal
National Registry of Emergency Medical Technicians
3 shared publications - Beena Devi Kamath-Rayne
American Academy of Pediatrics, Itasca, USA
3 shared publications - Comilla Sasson
American Heart Association
3 shared publications - Dianne L. Atkins
University of Iowa
3 shared publications - Jill M. Mhyre
Department of Anesthesiology, University of Arkansas for Medical Sciences (UAMS), Little Rock, AR
3 shared publications
Latest Publications
- Open Access
- 7 August 2025
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 147 (1) , 97-107
Artificial Intelligence for the Detection of Fetal Ultrasound Findings Concerning for Major Congenital Heart Defects
OBJECTIVE: To evaluate the performance of an artificial intelligence (AI)–based software to identify second-trimester fetal ultrasound examinations suspicious for congenital heart defects. METHODS: The software analyzes all grayscale two-dimensional ultrasound cine clips of an examination to evaluate eight morphologic findings associated with severe congenital heart defects. A data set of 877 examinations was retrospectively collected from 11 centers. The presence of suspicious findings was determined by a panel of expert pediatric cardiologists, who determined that 311 examinations had at least one of the eight suspicious findings. The AI software processed each examination, labeling each finding as present, absent, or inconclusive. RESULTS: Of the 280 examinations with known severe congenital heart defects, 278 (sensitivity 0.993, 95% CI, 0.974–0.998) had at least one of the eight suspicious findings present as determined by the fetal cardiologists, highlighting the relevance of these eight findings. We then evaluated the performance of the AI software, which identified at least one finding as present in 271 examinations, that all eight findings were absent in five examinations, and was inconclusive in four of the 280 examinations with severe congenital heart defects, yielding a sensitivity of 0.968 (95% CI, 0.940–0.983) for severe congenital heart defects. When comparing the AI to the determination of findings by fetal cardiologists, the detection of any finding by the AI had a sensitivity of 0.987 (95% CI, 0.967–0.995) and a specificity of 0.977 (95% CI, 0.961–0.986) after exclusion of inconclusive examinations. The AI rendered a decision for any finding (either present or absent) in 98.7% of examinations. CONCLUSION: The AI-based software demonstrated high accuracy in identification of suspicious findings associated with severe congenital heart defects, yielding a high sensitivity for detecting severe congenital heart defects. These results show that AI has potential to improve antenatal congenital heart defect detection.
- 7 August 2025
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 147 (1) , 97-107
Open AccessArtificial Intelligence for the Detection of Fetal Ultrasound Findings Concerning for Major Congenital Heart Defects
OBJECTIVE: To evaluate the performance of an artificial intelligence (AI)–based software to identify second-trimester fetal ultrasound examinations suspicious for congenital heart defects. METHODS: The software analyzes all grayscale two-dimensional ultrasound cine clips of an examination to evaluate eight morphologic findings associated with severe congenital heart defects. A data set of 877 examinations was retrospectively collected from 11 centers. The presence of suspicious findings was determined by a panel of expert pediatric cardiologists, who determined that 311 examinations had at least one of the eight suspicious findings. The AI software processed each examination, labeling each finding as present, absent, or inconclusive. RESULTS: Of the 280 examinations with known severe congenital heart defects, 278 (sensitivity 0.993, 95% CI, 0.974–0.998) had at least one of the eight suspicious findings present as determined by the fetal cardiologists, highlighting the relevance of these eight findings. We then evaluated the performance of the AI software, which identified at least one finding as present in 271 examinations, that all eight findings were absent in five examinations, and was inconclusive in four of the 280 examinations with severe congenital heart defects, yielding a sensitivity of 0.968 (95% CI, 0.940–0.983) for severe congenital heart defects. When comparing the AI to the determination of findings by fetal cardiologists, the detection of any finding by the AI had a sensitivity of 0.987 (95% CI, 0.967–0.995) and a specificity of 0.977 (95% CI, 0.961–0.986) after exclusion of inconclusive examinations. The AI rendered a decision for any finding (either present or absent) in 98.7% of examinations. CONCLUSION: The AI-based software demonstrated high accuracy in identification of suspicious findings associated with severe congenital heart defects, yielding a high sensitivity for detecting severe congenital heart defects. These results show that AI has potential to improve antenatal congenital heart defect detection.
- 1 April 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 15 (4) , 302-317
2022 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With The Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration With the American Academy of Pediatrics, American Association for Respiratory Care, the Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists
- 1 April 2022
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 15 (4) , 302-317
2022 Interim Guidance to Health Care Providers for Basic and Advanced Cardiac Life Support in Adults, Children, and Neonates With Suspected or Confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get With The Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association in Collaboration With the American Academy of Pediatrics, American Association for Respiratory Care, the Society of Critical Care Anesthesiologists, and American Society of Anesthesiologists
- 1 July 2021
- Published by Elsevier in Resuscitation
- Vol. 164, 40-45
Factors associated with non-survival from in-hospital maternal cardiac arrest: An analysis of Get With The Guidelines® (GWTG) data
- 1 July 2021
- Published by Elsevier in Resuscitation
- Vol. 164, 40-45
Factors associated with non-survival from in-hospital maternal cardiac arrest: An analysis of Get With The Guidelines® (GWTG) data
- Open Access
- 1 November 2020
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 17 (11) , S447-S458
ACR Appropriateness Criteria® Nuchal Translucency Evaluation at 11 to 14 Weeks of Gestation
- 1 November 2020
- Published by Elsevier in Journal of the American College of Radiology
- Vol. 17 (11) , S447-S458
Open AccessACR Appropriateness Criteria® Nuchal Translucency Evaluation at 11 to 14 Weeks of Gestation
- 3 August 2020
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (15) , 3016-3019
COVID-19 in pregnancy: possible mechanisms not to be discounted
SARS-CoV-2 has infected more than 16 million people worldwide. Related complications and death from COVID-19 disease and their underlying pathophysiology are intensely investigated. Pregnant women are among the affected. Although the severity of disease in pregnancy does not appear to be increased, the effects of infection on pregnancy should not escape careful examination. The currently known receptor for the virus, ACE2, regulates the renin-angiotensin system and is increased during pregnancy. Virus–receptor interactions may have significant effects on placental function, fetal development, and maternal immunity. The manifestation of cardiovascular complications of infection produces the hypothesis that a significant effect of the virus may be its influence on the maternal vascular system. Interference with the vascular adaptations to pregnancy and the post-partum may have implications for concurrent and future pregnancies as well as for long-term cardiovascular health. We should not miss the opportunity to learn from this virus about the physiology of pregnancy.
- 3 August 2020
- Published by Taylor & Francis in The Journal of Maternal-Fetal & Neonatal Medicine
- Vol. 35 (15) , 3016-3019
COVID-19 in pregnancy: possible mechanisms not to be discounted
SARS-CoV-2 has infected more than 16 million people worldwide. Related complications and death from COVID-19 disease and their underlying pathophysiology are intensely investigated. Pregnant women are among the affected. Although the severity of disease in pregnancy does not appear to be increased, the effects of infection on pregnancy should not escape careful examination. The currently known receptor for the virus, ACE2, regulates the renin-angiotensin system and is increased during pregnancy. Virus–receptor interactions may have significant effects on placental function, fetal development, and maternal immunity. The manifestation of cardiovascular complications of infection produces the hypothesis that a significant effect of the virus may be its influence on the maternal vascular system. Interference with the vascular adaptations to pregnancy and the post-partum may have implications for concurrent and future pregnancies as well as for long-term cardiovascular health. We should not miss the opportunity to learn from this virus about the physiology of pregnancy.
- Open Access
- 4 May 2020
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- p. e20201405
Interim Guidance for Basic and Advanced Life Support in Children and Neonates With Suspected or Confirmed COVID-19
- 4 May 2020
- Published by American Academy of Pediatrics (AAP) in Pediatrics
- p. e20201405
Open AccessInterim Guidance for Basic and Advanced Life Support in Children and Neonates With Suspected or Confirmed COVID-19
- 1 January 2019
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 220 (1) , 123-124
Reply
- 1 January 2019
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 220 (1) , 123-124
Reply
- 1 November 2018
- Published by Elsevier in Resuscitation
- Vol. 132, 17-20
Characteristics and outcomes of maternal cardiac arrest: A descriptive analysis of Get with the guidelines data
- 1 November 2018
- Published by Elsevier in Resuscitation
- Vol. 132, 17-20
Characteristics and outcomes of maternal cardiac arrest: A descriptive analysis of Get with the guidelines data